2023 Year in Review
Over the 12 months of 2023, the SITC family dedicated energy and expertise to a set of incredibly strategic and impactful initiatives in support of our mission: to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation, diversity and inclusion and leadership in the field.
Leisha A. Emens, MD, PhD, SITC President
![](https://higherlogicdownload.s3.amazonaws.com/SITCANCER/58a96407-f19e-4f7a-be76-233d09840593/UploadedImages/Emens__Leisha_2023.jpg)